Evaluation of FROM-16 in ATMP Patients & Families

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

December 9, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
Family MembersCancer
Interventions
OTHER

FROM-16 Questionnaire

A 16-item questionnaire to provide information about the impact of a patient's disease/condition the participants (family member of patient) quality of life

OTHER

Semi-structured two-part interview

A telephone/video interview to provide additional context to the FROM-16 responses

Trial Locations (5)

B15 2GW

University Hospitals Birmingham NHS Foundation Trust, Birmingham

BS1 3NU

University Hospitals Bristol and Weston NHS Foundation Trust1, Bristol

CF14 4HH

Cardiff & Vale University LHB, Cardiff

LE1 5WW

University Hospitals of Leicester NHS Trust, Leicester

SA1 8EN

Swansea University School of Management, Swansea

All Listed Sponsors
collaborator

Cardiff University

OTHER

collaborator

University of Hertfordshire

OTHER

collaborator

Cardiff and Vale University Health Board

OTHER_GOV

collaborator

University Hospital Birmingham NHS Foundation Trust

OTHER

collaborator

University Hospitals, Leicester

OTHER

collaborator

University Hospitals Bristol and Weston NHS Foundation Trust

OTHER

lead

Swansea University

OTHER

NCT05141318 - Evaluation of FROM-16 in ATMP Patients & Families | Biotech Hunter | Biotech Hunter